(Q51286024)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420571%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Limited generation of activated protein C during infusion of the protein C activator thrombin analog W215A/E217A in primates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420571%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420571%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

6

Hanson SR

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420571%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

4

Marzec U

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420571%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Fernández JA

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420571%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Bush L

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420571%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Griffin JH

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420571%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

DI Cera E

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420571%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 February 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420571%20AND%20SRC:MED&resulttype=core&format=json

Journal of Thrombosis and Haemostasis

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420571%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420571%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

392-397

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420571%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420571%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

cites work

The Protein C Pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01760.X

Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01760.X

Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01760.X

Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01760.X

Pharmacokinetic-pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01760.X

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01760.X

Preparation and properties of bovine factor VIII (antihemophilic factor).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01760.X

Activation of endothelial cell protease activated receptor 1 by the protein C pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01760.X

Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01760.X

Conversion of thrombin into an anticoagulant by protein engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01760.X

Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01760.X

Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01760.X

Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01760.X

Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01760.X

Vascular immunotargeting of glucose oxidase to the endothelial antigens induces distinct forms of oxidant acute lung injury: targeting to thrombomodulin, but not to PECAM-1, causes pulmonary thrombosis and neutrophil transmigration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01760.X

The prolonged bleeding time in hemophilia A: comparison of two measuring technics and clinical associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01760.X

Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01760.X